The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol

Haryana M. Dhillon, Hidde P. van der Ploeg, Melanie L Bell, Michael Boyer, Stephen Clarke, Janette Vardy

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The Physical Activity in Lung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.Methods/design: A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.Discussion: This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.Trial registration: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235.

Original languageEnglish (US)
Article number572
JournalBMC Cancer
Volume12
DOIs
StatePublished - Dec 5 2012
Externally publishedYes

Fingerprint

Clinical Protocols
Fatigue
Lung Neoplasms
Randomized Controlled Trials
Quality of Life
Exercise
Neoplasms
Aptitude
Somatomedins
Body Composition
New Zealand
Dyspnea
Lung Diseases
Registries
Colorectal Neoplasms
Hospitalization
Anxiety
Clinical Trials
Depression
Breast Neoplasms

Keywords

  • Exercise
  • Fatigue
  • Lung cancer
  • Physical activity
  • Quality of life

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics

Cite this

The impact of physical activity on fatigue and quality of life in lung cancer patients : A randomised controlled trial protocol. / Dhillon, Haryana M.; van der Ploeg, Hidde P.; Bell, Melanie L; Boyer, Michael; Clarke, Stephen; Vardy, Janette.

In: BMC Cancer, Vol. 12, 572, 05.12.2012.

Research output: Contribution to journalArticle

Dhillon, Haryana M. ; van der Ploeg, Hidde P. ; Bell, Melanie L ; Boyer, Michael ; Clarke, Stephen ; Vardy, Janette. / The impact of physical activity on fatigue and quality of life in lung cancer patients : A randomised controlled trial protocol. In: BMC Cancer. 2012 ; Vol. 12.
@article{078e1b3df52a432aad08c2feca18648c,
title = "The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol",
abstract = "Background: People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The Physical Activity in Lung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.Methods/design: A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.Discussion: This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.Trial registration: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235.",
keywords = "Exercise, Fatigue, Lung cancer, Physical activity, Quality of life",
author = "Dhillon, {Haryana M.} and {van der Ploeg}, {Hidde P.} and Bell, {Melanie L} and Michael Boyer and Stephen Clarke and Janette Vardy",
year = "2012",
month = "12",
day = "5",
doi = "10.1186/1471-2407-12-572",
language = "English (US)",
volume = "12",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The impact of physical activity on fatigue and quality of life in lung cancer patients

T2 - A randomised controlled trial protocol

AU - Dhillon, Haryana M.

AU - van der Ploeg, Hidde P.

AU - Bell, Melanie L

AU - Boyer, Michael

AU - Clarke, Stephen

AU - Vardy, Janette

PY - 2012/12/5

Y1 - 2012/12/5

N2 - Background: People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The Physical Activity in Lung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.Methods/design: A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.Discussion: This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.Trial registration: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235.

AB - Background: People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The Physical Activity in Lung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.Methods/design: A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.Discussion: This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.Trial registration: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235.

KW - Exercise

KW - Fatigue

KW - Lung cancer

KW - Physical activity

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84870352911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870352911&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-12-572

DO - 10.1186/1471-2407-12-572

M3 - Article

C2 - 23216897

AN - SCOPUS:84870352911

VL - 12

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 572

ER -